• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    AGC Biologics Appoints Jun Takami GM of Chiba Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology

    Moderna, Catalent Enter Long-Term Strategic Vax Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

    Alkermes, Merck Enter Clinical Trial and Supply Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Emergent BioSolutions

    Quotient Sciences

    Alcami

    PCI Pharma Services

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Adare Pharma Solutions

    Alcami

    Syngene

    Emergent BioSolutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    Post-Pandemic Regulations

    Envisioning clinical development regulatory practices in a post-pandemic world.

    Post-Pandemic Regulations
    Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA04.01.21
    During the COVID-19 pandemic, we saw the pharmaceutical sector—including key industry players and regulators around the globe—work collaboratively to rapidly develop and deliver diagnostic tests, treatments and vaccines at breakneck speeds. The incredible success of these efforts has truly shown what the industry is capable of, even under lockdown. This has contributed to the upending of traditional regulatory practices. With vaccine distribution now underway, life sciences companies and regulators alike will need to reflect on what will realistically return to its pre-COVID state and what will benefit from long-term change in regulatory compliance.

    With new COVID-19 virus strains being discovered and COVID treatments continuing to be developed, demands for faster clinical development have become even more pressing—resulting in many traditional clinical processes taking on new formats to increase efficiencies. These new formats include a decentralized approach to collecting patient information and rapid access to regulators in order to assess plans and changes to ongoing studies in near real-time. One example of this is with pre-investigational new drug (IND) meetings with the U.S. FDA. During the pandemic, some of these meetings have been granted in under 30 days, with select flexibility around the need to include non-clinical information in order to accelerate the review and initiation of studies.

    Additionally, regulatory agencies can complete rolling reviews of the information to accelerate emergency use authorization (EUA) approvals, rather than wait for a full dossier of information for a new drug application (NDA). This process ensures a key balance of safety and efficiency by assessing the risk benefits of a drug or treatment and generally requires a very robust post-EUA safety surveillance plan, or pharmacovigilance strategy, to ensure early detection of potential issues prior to clinical trial studies. On the road ahead, decentralized clinical trials and rolling NDA reviews may become more common.

    In tandem with a decentralized approach to gathering patient information, the execution of clinical trials has followed suit, spurring a need for new regulatory guidance in the process. Through more rapid and diverse patient recruitment and increased retention rates, decentralized and hybrid clinical trials offer faster start-up times, greater efficiencies and higher return on investment. However, scaling up this format, which has historically been based on mobile health apps and restricted to smaller, less complex studies, will require rigorous regulatory compliance practices to ensure meeting the same standard of quality as traditional trials. Pharmaceutical companies will be challenged with implementing the right technology to balance speed with regulatory compliance. Through this process, automation of data capture and reporting will be critical capabilities to ensure accuracy and completeness of submissions that translate to compliant products.

    Although many processes throughout the drug development lifecycle are changing due to the increased need for accelerated clinical development, required adherence to safety regulations from regulatory agencies will not. In fact, the FDA has issued 74 new COVID-specific guidance documents since March 2020 and is anticipated to issue more in the coming months. Consequently, pharmaceutical companies are eager to discover new methods to maintain collaborative efforts with regulators and keep up with evolving regulations, while maintaining new clinical development speed and efficiencies.

    To address this, pharmaceutical companies are looking at new ways to use regulatory intelligence to drive workstreams and automate the more repetitive, tedious regulatory reporting tasks. Such regulatory tasks traditionally take place in siloed teams within pharmaceutical companies, separate from other functional groups (e.g., safety and quality teams). Cloud-based technology is critical to driving efficiency, as it allows teams to work more easily and collaboratively remotely as well as outsource more tasks. Through the power of artificial intelligence (AI) and machine learning (ML), regulatory groups can share data and join forces with safety and quality teams to integrate operations, as well as embrace a more outsourced model and leverage external resources to help increase regulatory information management efficiencies.

    Furthermore, real-world data (RWD) and simulation data gathering will play a key role in the development of new treatments. Initially, pharmaceutical companies did not prioritize the use of real-world data due to a lack of resources and infrastructure to gather and screen it. With broadened COVID-19-related experience illustrating the inherent value, the industry is more accepting of such novel approaches to data. By embracing these new digital processes, clinical study leaders can more rapidly collect necessary data and help ensure patient safety and adherence to protocols and regulatory requirements. 

    The pandemic not only exposed gaps within current regulatory practices, but also catalyzed a digital transformation within the industry, driven by the need for speed and efficiency. In the next year, the industry will continue to collaborate with health authorities and adopt innovative technology to redefine its traditional processes. 

    Related Back Page

    • Aseptic Processing | Facilities | Fill/Finish | Parenterals
      The Future of Pharmaceutical Manufacturing

      The Future of Pharmaceutical Manufacturing

      Innovative multi-product facility and equipment design.
      Steve Nole, VP of Operations, Grand River Aseptic Manufacturing 01.27.21

    • Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Supply chain management for cell and gene therapies requires precise demand planning and forecasting.
      Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | R&D
      The Global Biotech Boom

      The Global Biotech Boom

      How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.
      Davide Garrisi, PPD Biotech 09.09.20


    • Speeding Vaccine Development with Advanced Analytics

      Speeding Vaccine Development with Advanced Analytics

      Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development process
      Dr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 05.05.20

    • APIs
      SOPs to Spur Growth in API Manufacturing

      SOPs to Spur Growth in API Manufacturing

      CMOs see outsourcing prospects improve
      S. Harachand, Contributing Editor 04.01.20

    • Trends Affecting the Generic Drugs Sector in 2020

      Trends Affecting the Generic Drugs Sector in 2020

      Supply chain issues, the need for additional talent chemists, lower drug prices, growth of development in the U.S. will be key factors.
      Ed Price, President, Seqens NA 03.04.20


    • QA/QC
      Quality Management: Preserving and Perpetuating Your Record

      Quality Management: Preserving and Perpetuating Your Record

      CDMOs must ensure that their top priority be delivering the highest quality products.
      Colleen Herczak, Vice President of Quality, Grand River Aseptic Manufacturing 01.28.20

    • Injectables
      Pitfalls to Avoid When Packaging Injectable Drug Products

      Pitfalls to Avoid When Packaging Injectable Drug Products

      Addressing legacy systems, lack of innovation adoption, and special challenges of New Molecular Entities.
      Fran DeGrazio, VP, Scientific Affairs and Technical Services, West Pharmaceutical Services 11.20.19

    • Information Technology
      Data Management in Life Sciences: Then and Now

      Data Management in Life Sciences: Then and Now

      A look at landmark changes in the management of data in the life sciences over the last 20 years and how the industry has addressed the challenges these develop
      Jason Lacombe, CEO, Veratrak 10.15.19


    • Clinical Trials | Information Technology
      Virtual Trials: Are they living up to their hype?

      Virtual Trials: Are they living up to their hype?

      This innovative approach is less costly, more patient-friendly, and delivers better quality data however, many stakeholders are still uncertain
      Josh Rose, VP R&D Global Strategy and Head of Virtual Trial Solutions, IQVIA 09.16.19

    • Avoiding Death by Spreadsheet

      Avoiding Death by Spreadsheet

      Cloud ERP systems are ushering in a new era of supply chain management
      Michael Kolias, QAD 06.13.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biotech Booms in the Yangtze River Valley

      Biotech Booms in the Yangtze River Valley

      A look at forces shaping the course of biotech growth in China
      Daniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19


    • India Eases Price Control  On Novel Drugs

      India Eases Price Control On Novel Drugs

      No price cap for innovator products for 5 years
      S. Harachand, Contributing Editor 03.06.19

    • Logistics | Supply Chain
      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      The role of pharmaceutical distributors in the increasingly complex supply chain
      Akin Odutola, AmerisourceBergen 01.25.19

    • Injectables | Parenterals
      Injectables Go Deeper

      Injectables Go Deeper

      Generic majors set sights on complex sterile injectables
      S. Harachand, Contributing Editor 11.14.18

    Trending
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Alkermes, Merck Enter Clinical Trial And Supply Agreement
    • Ascendia Pharmaceuticals Poised For Expansion
    • Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
    Breaking News
    • Bora Pharmaceuticals Adds Roller Compaction Capabilities
    • Ascendia Pharmaceuticals Poised for Expansion
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Chromaflo Technologies Awarded Gold Status CSR Rating by EcoVadis in EMEA
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands 'Beautiful' Fagrance Collection
    Mushrooms Are Key Ingredients in Beauty & Wellness
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login